CTRM
Castor Maritime Inc.
There isn't enough reported data to score CTRM yet.
EOSE
Eos Energy Enterprises, Inc.
There isn't enough reported data to score EOSE yet.
CTRM Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| Unavailable | |
| Strong |
CTRM's profitability and balance sheet are currently healthy. There isn't enough data to rate its revenue and cash flow.
EOSE Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
EOSE's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
CTRM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 0.4x | $1.31 | — |
| Cheap | 0.5x | $1.82 | +39% |
| Fair | 1x | $3.44 | +163% |
| Expensive | 1.9x | $6.31 | +382% |
Historical ranges are pointers, not guarantees.
CTRM's PE is 0.4x, but its earnings don't support one, so it isn't a reliable read right now.
EOSE PE Valuation
EOSE has no meaningful PE right now: it lost money over the past year.
CTRM Forward outlook
There aren't enough analyst estimates for CTRM to show an outlook.
EOSE Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect EOSE's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
CTRM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $3.32 | +$6.89 |
| Q4 2025 | $0.36 | -5.3% |
| Q4 2024 | $0.38 | -78% |
| Q4 2023 | $1.70 | -86% |
| Q2 2023 | $9.50 | +9.2% |
| Q4 2022 | $12.50 | +166% |
CTRM has the edge over EOSE in the latest year-over-year earnings comparison.
EOSE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2023 | -$2.69 | +$0.85 |
| Q2 2023 | -$3.76 | -$1.00 |
| Q1 2023 | -$3.65 | -$0.86 |
| Q4 2022 | -$3.68 | -$1.32 |
| Q3 2022 | -$3.54 | +$5.19 |
EOSE is still losing money, but less than at its worst: $4.55 per share over the past year, against $8.73 at its worst in late 2021.
CTRM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $46.8M | +22% |
| Q4 2025 | $43.5M | +47% |
| Q2 2025 | $38.3M | +4.4% |
| Q4 2024 | $29.6M | -70% |
| Q2 2024 | $36.7M | -26% |
| Q4 2023 | $97.5M | -30% |
| Q2 2023 | $49.7M | -59% |
| Q4 2022 | $140M | +36% |
CTRM's revenue is recovering but still below its 2022 peak: $47M last quarter, up 28% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 156% | +81 points |
| Q4 2025 | 36% | +14 points |
| Q2 2025 | -90% | -111 points |
| Q4 2024 | -20% | -74 points |
| Q2 2024 | 75% | +33 points |
| Q4 2023 | 23% | -23 points |
| Q2 2023 | 22% | -8 points |
| Q4 2022 | 54% | +65 points |
CTRM has the edge over EOSE on profitability, with a higher operating margin.
EOSE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $82.7M | +171% |
| Q2 2026 | $68.8M | +351% |
| Q1 2026 | $57M | +445% |
| Q4 2025 | $58M | +700% |
| Q3 2025 | $30.5M | +3473% |
| Q2 2025 | $15.2M | +1597% |
| Q1 2025 | $10.5M | +58% |
| Q4 2024 | $7.3M | +9.7% |
EOSE has the edge over CTRM in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -96% | +105 points |
| Q2 2026 | -122% | +297 points |
| Q1 2026 | -139% | +367 points |
| Q4 2025 | -140% | +573 points |
| Q3 2025 | -201% | +6044 points |
| Q2 2025 | -419% | +2815 points |
| Q1 2025 | -506% | +117 points |
| Q4 2024 | -713% | -74 points |
EOSE's operating margin was −96% last quarter, up 105 points from the same quarter a year ago, near the top of its range since 2019.
CTRM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$62.8M | -$58.6M |
| Q4 2025 | $13.6M | +$67.7M |
| Q2 2025 | -$4.2M | -118% |
| Q4 2024 | -$54.1M | -351% |
| Q2 2024 | $23.8M | +186% |
| Q4 2023 | $21.6M | +22% |
| Q2 2023 | $8.3M | -72% |
| Q4 2022 | $17.6M | +$64.4M |
CTRM's free cash flow was −$108M over the past year, against $71M the year before.
EOSE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$105.1M | -$22.4M |
| Q2 2026 | -$107.4M | -$34.3M |
| Q1 2026 | -$154.8M | -$121M |
| Q4 2025 | -$75.2M | -$19.5M |
| Q3 2025 | -$82.7M | -$28.5M |
| Q2 2025 | -$73.2M | -$40.6M |
| Q1 2025 | -$33.8M | +$10.7M |
| Q4 2024 | -$55.8M | -$10.2M |
EOSE has burned cash in almost every quarter: −$443M over the past year, against −$246M the year before.
CTRM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +502% | +48.5M shares |
| 1 year | +514% | +48.7M shares |
| 3 years | +242296% | +58.2M shares |
CTRM has 58M diluted shares, up 514% from a year ago.
EOSE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +63% | +213M shares |
| 1 year | +161% | +341M shares |
| 3 years | +888% | +497M shares |
EOSE has the edge over CTRM on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
CTRM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2023 | -0.6x | Net Cash |
| Q2 2023 | 0.8x | Very low |
| Q4 2022 | 0.1x | Very low |
| Q2 2022 | 0.3x | Very low |
| Q4 2021 | 0.9x | Very low |
| Q2 2021 | 0.3x | Very low |
| Q4 2020 | 1.8x | Healthy |
CTRM has more cash than debt.
EOSE Net Leverage
EOSE's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CTRM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 29.4 | Oversold |
| Stochastic | 4.8 | Oversold |
CTRM's weekly RSI is 29 (oversold) and its Stochastic is 5 (oversold).
EOSE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.5 | Neutral |
| Stochastic | 7.4 | Oversold |
EOSE's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
CTRM PE vs Industrials Sector
| Metric | CTRM | Sector median | Relative |
|---|---|---|---|
| PE | 0.4x | 24x | 98% below |
| PE % | 1 | 59 | 58 pts below |
CTRM is trading at 0.4x earnings, a 98% discount to the Industrials sector's median of 24x, though its earnings don't support one.
EOSE PE vs Industrials Sector
EOSE has no meaningful PE right now: it lost money over the past year.
CTRM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.65 | 21% below |
| 20 week MA | $1.98 | 34% below |
| 50 week MA | $2.04 | 36% below |
| 100 week MA | $2.17 | 40% below |
EOSE has stronger trend alignment. CTRM is above 0 of 4 weekly averages versus EOSE above 0 of 5.
EOSE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.24 | 19% below |
| 20 week MA | $3.28 | 45% below |
| 50 week MA | $7.01 | 74% below |
| 100 week MA | $7.10 | 75% below |
| 200 week MA | $4.53 | 60% below |
EOSE is in a downtrend: it's below all five of its weekly moving averages, and 60% below its 200-week average.
CTRM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $8.84 | $4.25 | -52% |
| 2024 | $4.25 | $2.88 | -32% |
| 2025 | $2.88 | $2.32 | -19% |
| 2026 YTD | $2.32 | $1.31 | -44% |
CTRM has the edge over EOSE on returns for 2026, with the stronger performance.
EOSE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.72 | $19.2 | +98% |
| 2021 | $19.2 | $8.57 | -55% |
| 2022 | $8.57 | $1.08 | -87% |
| 2023 | $1.08 | $1.09 | +0.9% |
| 2024 | $1.09 | $5.17 | +374% |
| 2025 | $5.17 | $11.9 | +129% |
| 2026 YTD | $11.9 | $1.81 | -85% |
EOSE's yearly returns have swung widely, from +374% in 2024 to −87% in 2022. It's down 85% so far in 2026.